Centre for Children and Young People's Health Research (CYPHR)

Enabling Next Generation Additive Manufacturing for Pharma and related industries:

New major programme funded by EPSRC

The University of Nottingham has been awarded £5.9M to establish next generation multifunctional additive manufacturing (‘3D printing’) and to translate this to industry and researchers focussing on novel electronic and pharmaceutical/healthcare applications. The project led by Prof Richard Hague (School of Engineering) is in collaboration with Prof Clive Roberts in the School of Pharmacy as well as colleagues from Physics and the Universities of Warwick and Birmingham. The primary challenge is at the interface of the materials deposited during printing. This programme will focus on overcoming the challenges of spatially controlled co-deposition of dissimilar materials in 3D and aims to establish new understanding and methods of both modelling and controlling co-deposition. 

This new project builds on other programmes in collaboration with the Centre for Additive Manufacturing in the School of Engineering at Nottingham for the development of 3D printed medicines, in particular with GSK and AstraZeneca such as the EPSRC £3.5M project, ‘Formulation for 3D printing: Creating a plug and play platform for a disruptive UK industry’ led by Prof Ricky Wildman with Profs Clive Roberts and Morgan Alexander from the School of Pharmacy.

Posted on Wednesday 20th October 2021

Centre for Children and Young People's Health Research (CYPHR)

The University of Nottingham
University Park
Nottingham, NG7 2RD